GEN Exclusives

More »

GEN News Highlights

More »
Aug 22, 2014

EMD Millipore Inks Biomanufacturing Deal with Samsung BioLogics

  • EMD Millipore and Samsung BioLogics signed a Memorandum of Understanding (MOU) for a strategic alliance to encompass a long-term supply agreement in which EMD Millipore will provide raw materials for biopharmaceutical manufacturing.

    “Our latest partnership in the biopharmaceutical sector will further strengthen the great relationship built in other business areas for the past years. It will also help us support Samsung’s initiative in the CMO and biopharmaceutical field,” said Udit Batra, Ph.D., president and CEO of EMD Millipore.

    EMD Millipore will become an essential raw material supplier for Samsung BioLogics’ 30 KL facility as well as its new 150 KL facility that is expected to be completed in 2015 at Songdo, Incheon, Korea.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Block That Microbiome Metaphor!

Which way of thinking about the microbiome would best integrate the virome’s contributions?